Literature DB >> 9673449

Gene regulation by vitamin D3.

C Carlberg1, P Polly.   

Abstract

The physiologically active form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3 (VD), is a nuclear hormone with pleiotropic action on the control of calcium homeostasis and bone formation, induction of cellular differentiation and apoptosis, inhibition of cellular proliferation, and other cellular signaling processes. The actions of the hormone are mediated by the vitamin D receptor (VDR), a transcription factor that is a nuclear receptor for VD and a member of the nuclear receptor superfamily. The structural relationship between the members of this transcription factor family suggests similar function in DNA binding, transactivation, and contact to other nuclear proteins. However, each nuclear receptor also demonstrates individual properties that are characteristic and not shared by its respective relatives. In this review, both common as well as individual characteristics of VDR-mediated transcriptional regulation are critically discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673449     DOI: 10.1615/critreveukargeneexpr.v8.i1.20

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  36 in total

1.  The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien.

Authors:  Udo Moehren; Uwe Dressel; Christina A Reeb; Sami Väisänen; Thomas W Dunlop; Carsten Carlberg; Aria Baniahmad
Journal:  Nucleic Acids Res       Date:  2004-06-01       Impact factor: 16.971

2.  Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization.

Authors:  Sami Väisänen; Juha Matilainen; Carsten Carlberg
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 3.  24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

Authors:  Wei Luo; Pamela A Hershberger; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

4.  Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines.

Authors:  Pit Sertznig; Markus Seifert; Wolfgang Tilgen; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2009-07

Review 5.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

6.  Vitamin D does not modulate NF-kappaB activity in Jurkat T cells.

Authors:  Amde Selassie Shifera; Deborah Leong; John A Hardin
Journal:  Immunol Lett       Date:  2010-04-10       Impact factor: 3.685

7.  1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.

Authors:  Xuanzhu Zhou; Wei Zheng; G A Nagana Gowda; Daniel Raftery; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

Review 8.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

Review 9.  Vitamin D Deficiency and Rheumatoid Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Marcimara Penitenti; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

10.  Quantification of the vitamin D receptor-coregulator interaction.

Authors:  Arnaud Teichert; Leggy A Arnold; Steve Otieno; Yuko Oda; Indre Augustinaite; Tim R Geistlinger; Richard W Kriwacki; R Kiplin Guy; Daniel D Bikle
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.